BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Dr Ian Smith Founder and Global Medical Director of Synexus Awarded an MBE in the Queen's New Years Honors List


1/9/2012 10:58:39 AM

Monday 9th January 2012 -- Dr Ian Smith was awarded an MBE ‘for services to Health Research’ in the Queen’s New Years honours list. Dr Smith is founder and global medical director of Synexus which has been attributed with pioneering important developments in the clinical trial industry. The business, which Dr Smith started in 1992, has since grown to become the world’s largest multinational company dedicated to the recruitment and running of clinical trials at its own dedicated research centres on behalf of its clients in pharma and CROs. Synexus has 26 research centres in nine countries across Asia, Africa and Europe.

Christophe Berthoux CEO of Synexus commented: “It is an incredible honour for Dr Smith to be recognised in this away. His vision, which became Synexus, was truly inspiring and has changed the way in which the industry recruits patients for, and runs, clinical trials. Synexus has expanded rapidly and has grown to become a positive advocate for science, and its development, here in the UK. Despite the overall trend of decline in clinical trials run in the UK Synexus has continued to increase the number of trials it runs here remaining committed to the quality and value the UK brings to the industry.”



Read at BioSpace.com

Synexus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES